Brookline Capital Management Predicts Medicus Pharma Q1 Earnings

Medicus Pharma Ltd. (NASDAQ:MDCX) – Equities research analysts at Brookline Capital Management issued their Q1 2025 earnings estimates for shares of Medicus Pharma in a report released on Tuesday, April 8th. Brookline Capital Management analyst K. Raja anticipates that the company will post earnings per share of ($0.23) for the quarter. Brookline Capital Management currently has a “Strong-Buy” rating on the stock. The consensus estimate for Medicus Pharma’s current full-year earnings is ($1.14) per share. Brookline Capital Management also issued estimates for Medicus Pharma’s Q2 2025 earnings at ($0.24) EPS, Q3 2025 earnings at ($0.19) EPS, Q4 2025 earnings at ($0.23) EPS and FY2029 earnings at $1.68 EPS.

Medicus Pharma (NASDAQ:MDCX) last issued its earnings results on Friday, March 28th. The company reported ($0.18) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.32) by $0.14.

Separately, Maxim Group began coverage on Medicus Pharma in a research report on Tuesday, December 17th. They issued a “buy” rating and a $10.00 target price for the company.

Medicus Pharma Stock Performance

NASDAQ MDCX opened at $3.58 on Thursday. Medicus Pharma has a twelve month low of $1.80 and a twelve month high of $6.00. The firm’s fifty day moving average price is $3.44.

Hedge Funds Weigh In On Medicus Pharma

A hedge fund recently bought a new stake in Medicus Pharma stock. Interchange Capital Partners LLC acquired a new position in Medicus Pharma Ltd. (NASDAQ:MDCX) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 1,457,165 shares of the company’s stock, valued at approximately $3,628,000. Medicus Pharma comprises about 1.3% of Interchange Capital Partners LLC’s investment portfolio, making the stock its 15th biggest position. Interchange Capital Partners LLC owned approximately 13.43% of Medicus Pharma at the end of the most recent reporting period.

About Medicus Pharma

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.